NCT02737046 2026-03-10
Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma
University of Miami
Phase 2 Completed
Clinical Trials
7 trialsNCT01626664 2024-04-25
KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)
Kyowa Kirin Co., Ltd.
Phase 2 Completed
NCT01724177 2018-05-29
A Phase 2 Study of Lenalidomide in Patients With Relapsed or Recurrent Adult T-cell Leukemia-lymphoma
Celgene
Phase 2 Completed
NCT01173887 2017-03-30
Multicenter, Randomized, Open-label, Parallel-group Study to Compare mLSG15 + KW-0761 to mLSG15
Kyowa Kirin Co., Ltd.
Phase 2 Completed
NCT00920790 2017-03-29
Phase II Study of KW-0761 in Subjects With CCR4-positive Adult T-cell Leukemia-lymphoma
Kyowa Kirin Co., Ltd.
Phase 2 Completed
NCT01274533 2016-05-23
Lenalidomide in HTLV-1 Adult T-Cell Leukemia
Columbia University
Phase 2 Completed
NCT00061048 2012-10-31
Campath-1H for Treating Adult T-Cell Leukemia/Lymphoma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed